Herantis Pharma Oyj

Prospectus ID: FIVA/2022/46

Passported to 1 EEA member state

Host member states notified under Art. 25 of Regulation (EU) 2017/1129.

First passporting notification
4 May 2022
Last passporting notification
4 May 2022
Home member state
Finland
Document type
Standalone prospectus
Prospectus type
Standalone Prospectus
Approval / filing date
3 May 2022
Issuer LEI
743700W4CQVYAT3WKK38
Language(s)
Finnish

ISINs

  • FI4000087861

Comment

EU RECOVERY PROSPECTUS

Last verified: 2 Nov 2026

Data sourced from the ESMA prospectus register, updated weekly.

See also

Full prospectus record → ESMA Prospectus Register

📋 Track EU financial regulation continuously

Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.

Start free trial → Learn more

14-day free trial. No credit card required.